News
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
There was no autopsy performed, but toxicology test results gave additional clarity, according to the medical examiner’s ...
The cause of death for actress Michelle Trachtenberg, who died in February, was confirmed to be complications of diabetes ...
Michelle Trachtenberg's death was initially undetermined but the medical examiner amended it after lab test results showed ...
Michelle Trachtenberg, an actress known for her work on 'Gossip Girl', died this year at age 39. Her cause of death was ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
NEW YORK (AP) — Actor Michelle Trachtenberg died as a result of complications from diabetes, New York City's medical examiner ...
Michelle Trachtenberg, who starred in “Buffy the Vampire Slayer” and “Gossip Girl,” died of diabetes complications at age 39, ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results